Social Sentiment for COLL
Bullish vs. Bearish opinions
Weighted Sentiment -0.30
Collegium Pharmaceutical Forecast and Stock Analysis
Technical COLL stock analysis for April 18, 2019.
Collegium Pharmaceutical fell by -0.66% in the last day from $13.61 to $13.52 and has now fallen 5 days in a row. The price has fallen in 7 of the last 10 days and is down by -15.87% for this period. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -80 305 shares and in total 424 940 shares bought and sold for approximately $5.75 million.
Close price at the end of the last trading day (Thursday, 18th Apr 2019) of the COLL stock was $13.52. This is 0.66% less than the trading day before Wednesday, 17th Apr 2019.
During day the stock fluctuated 4.91% from a day low at $13.23 to a day high of $13.88.
30 day high of the COLL stock price was $18.01 and low was $13.23.
90 day high was $18.88 and low was $13.10.
52 week high for the Collegium Pharmaceutical - $28.91 and low - $13.10.
Collegium Pharmaceutical has broken the very wide and weak rising short-term trend down. This signalize a slower rising rate, but may also be an early warning about a possible trend shift. Due to trend being broken there will now be resistance at the bottom line of the trend at $13.98. A reaction back to this level may hold a second chance to get out before further falls.
There are few to none technical positive signals at the moment. Collegium Pharmaceutical holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $15.07 and $16.41. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Friday April 12, 2019, which indicates further falls until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.
Relative Strength Index (RSI)
RSI14 is 35 and the stock is currently not being overbought or oversold
Support & Resistance
There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.65 between high and low, or 4.91%. For the last week, the stock has had a daily average volatility of 7.81%.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
Very Low Low Medium High Very High
Evaluation: Sell Candidate
The Collegium Pharmaceutical stock holds several negative signals and despite the positive trend we believe Collegium Pharmaceutical will perform weak in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.
|Golden Star Signal|
Get competitive edge
The signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives a very good return. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!
Get access to Golden Star list now
|COLL $13.52 ($-0.09 -0.66%)|
COLL is down $0.09 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for COLL based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the COLL analysis is free »
From Our Blog
- Trading With Moving Average
- Pivot Points
- Accumulated Volume - Support and Resistance
- Volume - The Indicator You Really Need to Know
- We Give Back!
- Better Buy: Amazon vs. Facebook
- Better Buy: Apple vs. Microsoft
- Relative Strength Index (RSI)
- How to Lose Money When Trading: Part 2
- How to Lose Money When Trading: A Trader is Born
- Our 2017 Christmas Donation
- The Golden Star
- Announcing Partnership With CityFALCON
- Why correct moving average matters
- NASDAQ down -4.17%. Our portfolio is up +8.56%
- New Feature Added: Golden Star Signal
- Pick a Winner With StockInvest.us